1. In vivoactivity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models
   Kenneth Kolinsky et al, 2009, Molecular Cancer Therapeutics CrossRef
2. Noninvasive Measurements of Capecitabine Metabolism in Bladder Tumors Overexpressing Thymidine Phosphorylase by Fluorine-19 Magnetic Resonance Spectroscopy
   Yuen-Li Chung et al, 2004, Clinical Cancer Research CrossRef
3. Phase I Study of Capecitabine With Concomitant Radiotherapy for Patients With Locally Advanced Pancreatic Cancer: Expression Analysis of Genes Related to Outcome
   M. Wasif Saif et al, 2005, Journal of Clinical Oncology CrossRef
4. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2’-deoxyuridine
   Tao Ma et al, 2004, World Journal of Gastroenterology CrossRef
5. Predictive factors for response to chemotherapy in colorectal cancer patients
   Bruno Vincenzi et al, 2004, Critical Reviews in Oncology/Hematology CrossRef
6. Thymidine phosphorylase and dihydropyrimidine dehydrogenase are predictive factors of therapeutic efficacy of capecitabine monotherapy for breast cancer-preliminary results
   Junko Honda et al, 2008, The Journal of Medical Investigation CrossRef